期刊
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
卷 2013, 期 17, 页码 3560-3566出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejoc.201300077
关键词
Medicinal chemistry; Peptidomimetics; Antibiotics; Foldamers; Macrocycles
资金
- National Science Foundation (NSF)
- MRI [DMR-0923251, CHE-1152317]
- National Institute of Allergy and Infectious Diseases (United States Public Health Service) [K22-AI079389]
- New York University School of Medicine Development Funds
- New York University Graduate School of Arts and Sciences (NYU-GSAS)
- American Heart Association [10PRE3420022]
- Direct For Mathematical & Physical Scien
- Division Of Chemistry [1152317] Funding Source: National Science Foundation
There is a significant unmet need for new antimicrobial agents that can address antimicrobial resistance. One promising group of antimicrobials is the antimicrobial peptides (AMPs) and their synthetic mimics. In particular, synthetic sequence-specific oligomers of N-substituted glycine, termed peptoids, have been found to show potent antimicrobial activity against bacterial pathogens in vitro and can act against the emergence of antimicrobial resistance. In this study, we evaluate the antimicrobial activity of cyclic peptoid oligomers against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). The presence of the macrocyclic constraints can enforce a globally amphiphilic organization of the peptoid side-chains. Several of these new amphiphilic compounds show potent and selective antimicrobial activity. Electron microscopy experiments demonstrate that the peptoids target and damage the MRSA cytoplasmic membrane through the formation of pores. These results substantiate the potential of peptoids as antimicrobial therapeutic agents for the treatment of S. aureus infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据